14.01.2013 Views

essays in public finance and industrial organization a dissertation ...

essays in public finance and industrial organization a dissertation ...

essays in public finance and industrial organization a dissertation ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CHAPTER 3. MEDIGAP 131<br />

levels <strong>in</strong> this area will reflect this propensity to travel.<br />

A more subtle concern is that the marg<strong>in</strong>al Medigap purchaser may be more<br />

(or less) likely to travel than the average Medicare beneficiary. If this is the case,<br />

then controll<strong>in</strong>g for average local health care utilization is <strong>in</strong>sufficient. Basically, the<br />

concern is that although most people <strong>in</strong> Rural Town, USA don’t travel to Big City,<br />

USA for care, the marg<strong>in</strong>al Medigap purchaser might be the type of person who does.<br />

A solution to this problem is to def<strong>in</strong>e markets broadly enough so that the closest Big<br />

City, USA is <strong>in</strong>cluded <strong>in</strong> the market. We believe this is exactly what we do by us<strong>in</strong>g<br />

HRRs to def<strong>in</strong>e local markets as these regions are constructed explicitly to <strong>in</strong>clude<br />

the major hospital where people travel for sophisticated treatment.<br />

Therefore, given a measure of costs which accounts for travel <strong>and</strong> the conservative<br />

def<strong>in</strong>ition of local areas, we th<strong>in</strong>k that the exclusion restriction is unlikely to be<br />

violated. Nevertheless, if out-of-HRR costs did somehow directly impact costs, it<br />

would downwardly bias the coefficient on Medgap, work<strong>in</strong>g aga<strong>in</strong>st the direction of<br />

our ma<strong>in</strong> f<strong>in</strong>d<strong>in</strong>g. 19<br />

Medicare Advantage<br />

A f<strong>in</strong>al topic of discussion is our proxy for the price <strong>and</strong> availability of Medicare<br />

Advantage coverage: a second order polynomial <strong>in</strong> the county-year specific MA pene-<br />

tration rate. Controll<strong>in</strong>g for the determ<strong>in</strong>ants of MA enrollment is important for the<br />

explanatory power of the choice equation as Medigap <strong>and</strong> MA are typically viewed as<br />

substitutes. For similar reasons, it is important to <strong>in</strong>clude MA enrollees <strong>in</strong> the sample<br />

of analysis as MA coverage is the relevant alternative coverage to consider for changes<br />

<strong>in</strong> the Medigap market. Yet for valid estimation, the variables used to predict MA<br />

choice must satisfy the exclusion restriction of not directly impact<strong>in</strong>g medical costs.<br />

Below we make the case for their exclusion.<br />

The ma<strong>in</strong> argument for the exogeneity of county-year specific MA penetration<br />

rates is that much of the variation <strong>in</strong> this variable is driven by high-level federal<br />

19 In this case, higher out-of-HRR costs would simultaneously shift <strong>in</strong>dividuals out of coverage<br />

through the <strong>in</strong>strument <strong>and</strong> <strong>in</strong>crease costs directly, creat<strong>in</strong>g a negative correlation between coverage<br />

<strong>and</strong> unobserved costs <strong>and</strong> bias<strong>in</strong>g downwards the coefficient on Medigap.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!